Vermilion Energy Inc. Confirms Q3 2024 Release Date and Conference Call Details
Get Alerts VET Hot Sheet
Join SI Premium – FREE
Conference Call and Webcast Details
Vermilion will discuss these results in a conference call and webcast presentation on
To join the conference call without operator assistance, you may register and enter your phone number at https://emportal.ink/3ZUSYC8 to receive an instant automated call back. You may also access the webcast at https://app.webinar.net/kjPaNn2Nev0. The webcast links, along with conference call slides, will be available on Vermilion's website at https://www.vermilionenergy.com/invest-with-us/events-presentations/ under Upcoming Events prior to the conference call. Participants who would like to submit questions ahead of time may do so by emailing [email protected].
About Vermilion
Vermilion is an international energy producer that seeks to create value through the acquisition, exploration, development and optimization of producing assets in
Vermilion's priorities are health and safety, the environment, and profitability, in that order. Nothing is more important to us than the safety of the public and those who work with us, and the protection of our natural surroundings. We have been recognized by leading ESG rating agencies for our transparency on and management of key environmental, social and governance issues. In addition, we emphasize strategic community investment in each of our operating areas.
Vermilion trades on the Toronto Stock Exchange and the New York Stock Exchange under the symbol VET.
View original content to download multimedia:https://www.prnewswire.com/news-releases/vermilion-energy-inc-confirms-q3-2024-release-date-and-conference-call-details-302285138.html
SOURCE Vermilion Energy Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AiRWA receives Nasdaq deficiency notice over late 10-K filing
- Tenon Medical prices $3M private placement with institutional investor
- NeOnc reports Phase 2a brain cancer trial results, plans FDA meeting
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share